sr141716 has been researched along with Atrophy, Muscle in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Combe, K; Lanchais, K; Le Bacquer, O; Van Den Berghe, L; Walrand, S | 1 |
1 other study(ies) available for sr141716 and Atrophy, Muscle
Article | Year |
---|---|
Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1-independent mechanism.
Topics: Animals; Calcium; Cannabinoid Receptor Antagonists; Dexamethasone; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Mice; Muscle Fibers, Skeletal; Muscular Atrophy; Protein Biosynthesis; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases | 2021 |